(UBX) Unity Biotechnology complete technical analysis [charts+indicators] | Buy/Sell Unity Biotechnology | (UBX) share price targets
Complete technical analysis of Unity Biotechnology (UBX) by charts plus indicators, forecast predictions and share price targets for Unity Biotechnology (UBX)
Unity Biotechnology trades in USA in Health Care sector.
10 day averaged volume of Unity Biotechnology is 196090
| Date | Daily Closing Price | Open | High | Low | Volume |
| 11 Fri Apr 2025 | 0.99 | 0.95 | 1.02 | 0.93 | 0.301 times |
| 10 Thu Apr 2025 | 0.96 | 0.95 | 0.96 | 0.92 | 0.413 times |
| 09 Wed Apr 2025 | 0.96 | 0.91 | 0.97 | 0.90 | 0.58 times |
| 08 Tue Apr 2025 | 0.88 | 1.05 | 1.07 | 0.85 | 1.316 times |
| 07 Mon Apr 2025 | 0.93 | 0.87 | 0.97 | 0.86 | 0.621 times |
| 04 Fri Apr 2025 | 0.90 | 1.00 | 1.00 | 0.88 | 1.077 times |
| 03 Thu Apr 2025 | 0.99 | 1.03 | 1.04 | 0.98 | 0.631 times |
| 02 Wed Apr 2025 | 1.06 | 0.98 | 1.09 | 0.95 | 1.995 times |
| 01 Tue Apr 2025 | 0.96 | 1.05 | 1.06 | 0.95 | 1.385 times |
| 31 Mon Mar 2025 | 1.04 | 1.20 | 1.22 | 1.01 | 1.296 times |
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 0.9 as stoploss in an intra day buy trade for a target of 1.31. However, stock will show a bearish move below 0.9.
Share price targets for Unity Biotechnology (UBX)
| Target Type | Value |
| Downside Target | 0.10 |
| Downside Target | 0.85 |
| Downside Target | 0.88 |
| Upside Target | 1.01 |
| Upside Target | 1.07 |
| Upside Target | 1.21 |
| Upside Target | 1.39 |
| Upside Target | 1.50 |
| Upside Target | 1.53 |
| Upside Target | 1.68 |
| Upside Target | 1.85 |
| Upside Target | 1.98 |
| Upside Target | 2.39 |
| Upside Target | 3.10 |
Intraday share price targets for Unity Biotechnology (UBX)
| Target Type | Value |
| Downside Intraday Target | 0.87 |
| Downside Intraday Target | 0.75 |
| Upside Intraday Target | 1.09 |
| Upside Intraday Target | 1.19 |
| Downside Intraday Target | 0.97 |
Weekly technical analysis of Unity Biotechnology (UBX)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 11 Fri Apr 2025 | 0.99 | 0.87 | 1.07 | 0.85 | 0.506 times |
| 04 Fri Apr 2025 | 0.90 | 1.20 | 1.22 | 0.88 | 0.597 times |
| 28 Fri Mar 2025 | 1.14 | 1.38 | 1.39 | 1.09 | 7.532 times |
| 21 Fri Mar 2025 | 1.83 | 1.78 | 1.85 | 1.68 | 0.39 times |
| 14 Fri Mar 2025 | 1.77 | 1.60 | 1.98 | 1.53 | 1.743 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Unity Biotechnology (UBX)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 11 Fri Apr 2025 | 0.99 | 1.05 | 1.09 | 0.85 | 0.434 times |
| 31 Mon Mar 2025 | 1.04 | 1.72 | 1.98 | 1.01 | 1.289 times |
| 28 Fri Feb 2025 | 1.71 | 2.18 | 2.39 | 1.50 | 0.28 times |
| 31 Fri Jan 2025 | 2.22 | 1.01 | 3.10 | 1.01 | 6.581 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Unity Biotechnology (UBX)
Price action analysis of Unity Biotechnology ( (UBX) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Unity Biotechnology ( (UBX) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Unity Biotechnology ( (UBX) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Unity Biotechnology ( (UBX) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Unity Biotechnology stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Unity Biotechnology in short term and the sell signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Unity Biotechnology Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Unity Biotechnology in short term and BUY signal is strong.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Unity Biotechnology is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.97 and Unity Biotechnology (UBX) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Unity Biotechnology (UBX) stock. Volume based technical analysis of Unity Biotechnology (UBX) stock is negative.
Unity Biotechnology Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Unity Biotechnology ( (UBX) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Unity Biotechnology ( (UBX) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Unity Biotechnology ( (UBX) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Unity Biotechnology ( (UBX) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Unity Biotechnology stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Unity Biotechnology in short term and the sell signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Unity Biotechnology Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Unity Biotechnology in short term and BUY signal is strong.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Unity Biotechnology is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.97 and Unity Biotechnology (UBX) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Unity Biotechnology (UBX) stock. Volume based technical analysis of Unity Biotechnology (UBX) stock is negative.
Unity Biotechnology Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.